Aurora Cannabis's Australian subsidiary MedReleaf Australia has entered into a distribution partnership with Leafio in order to expand patient access to trusted, safe, and effective medical cannabis across Australia.
"We are excited to join forces with Leafio to improve access to consistent, high-quality medical cannabis for Australian patients," says Stanley Sack, Interim Managing Director of MedReleaf Australia. "Our TGA-GMP certified products combined with Leafio's extensive sector knowledge and focus on clinician education, makes us ideal partners as we continue to grow our leadership in this important market."
"Together, Leafio and Aurora can reach more Australian patients through trusted medical channels, bolstering access to world-class products and expertise," said Nicole Le Maistre, General Manager of Leafio. "This partnership will deliver meaningful benefits to the region's medical cannabis industry, from enhanced research and product innovation to trusted education and improved patient outcomes."
For more information:
Aurora Cannabis Inc.
auroramj.com/
